Parasites, Hosts and Diseases

The Korea Society for Parasitology and Tropical Medicine (대한기생충학·열대의학회)
권호 표지
DOI QR코드

DOI QR Code

Seropositivity of Toxoplasmosis in Pregnant Women by ELISA at Minia University Hospital, Egypt

  • Kamal, Amany M. (Department of Parasitology, Faculty of Medicine, Minia University) ;
  • Ahmed, Azza K. (Department of Parasitology, Faculty of Medicine, Minia University) ;
  • Abdellatif, Manal Z.M. (Department of Parasitology, Faculty of Medicine, Minia University) ;
  • Tawfik, Mohamed (Department of Obstetrics and Gynecology, Faculty of Medicine, Minia University) ;
  • Hassan, Ebtesam E. (Department of Public Health and Preventive Medicine, Faculty of Medicine, Minia University)
  • Received : 2015.04.13
  • Accepted : 2015.09.03
  • Published : 2015.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Toxoplasmosis is considered as an important risk factor for bad obstetric history (BOH) and one of the major causes of congenitally acquired infections. The present study aimed to estimate the seropositivity of T. gondii infection and associated risk factors among the attendees of high risk pregnancy and low risk antenatal care clinic of Minia Maternity and Pediatric University Hospital, Minia, Egypt. The study was carried out from April 2013 to April 2014 through 2 phases, the first phase was case-control study, and the second phase was follow-up with intervention. A total of 120 high risk pregnant and 120 normal pregnant females were submitted to clinical examinations, serological screening for anti-Toxoplasma IgM and IgG antibodies by ELISA, and an interview questionnaire. Seropositive cases were subjected to spiramycin course treatment. The results showed that the seroprevalence of toxoplasmosis in high-risk pregnancy group was 50.8%, which was significantly different from that of normal pregnancy group (P<0.05). Analysis of seropositive women in relation to BOH showed that abortion was the commonest form of the pregnancy wastage (56.5%). The high prevalence of T. gondii seropositive cases was observed in the age group of 21-30 years. Post-delivery adverse outcome was observed in 80.3% of high-risk pregnancy group compared to 20% of normal pregnancy group. There was a statistically significant relationship between seropositivity and living in rural area, low socioeconomic level, and undercooked meat consumption (P<0.05). Serological screening for anti-Toxoplasma antibodies should be routine tests especially among high-risk pregnant women.

Keywords

References

  1. Dubey JP. Toxoplasmosis of Animals and Humans. Beltsville, Maryland, USA. CRC Press. 2010.
  2. Torgerson PR, Mastroiacovo P. Global burden of congenital toxoplasmosis: systematic review. Bull World Health Organ 2013; 91: 501-508. https://doi.org/10.2471/BLT.12.111732
  3. Fricker-Hidalgo H, Cimon B, Chemla C, Darde ML, Delhaes L, L'ollivier C, Godineau N, Houze S, Paris L, Quinio D, Robert-Gangneux F, Villard O, Villena I, Candolfi E, Pelloux H. Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study. J Clin Microbiol 2013; 51: 2103-2111. https://doi.org/10.1128/JCM.00169-13
  4. Sarkar MD, Anuradha B, Sharma N, Roy RN. Seropositivity of toxoplasmosis in antenatal women with bad obstetric history in a tertiary-care hospital of Andhra Pradesh, India. J Health Popul Nutr 2012; 30: 87-92.
  5. Kumari N, Morris N, Dutta R. Is screening of TORCH worthwhile in women with bad obstetric history: an observation from eastern Nepal. J Health Popul Nutr 2011; 29: 77-80.
  6. Yasodhara P, Ramalakshmi BA, Lakshmi V, Krishna TP. Socioeconomic status and prevalence of toxoplasmosis during pregnancy. Indian J Med Microbiol 2004; 22: 241-243.
  7. McLeod R, Remington JS. Toxoplasmosis (Toxoplasma gondii). In Behrman RE, Kliegman RM, Jenson HB, eds, Nelson Textbook of Pediatrics. 16th ed. Philadelphia, Pennsylvania, USA. WB Saunders. 2000, pp. 1054-1062.
  8. El Deeb HK, Salah-Eldin H, Khodeer S, Allah, AA. Prevalence of Toxoplasma gondii infection in antenatal population in Menoufia governorate, Egypt. Acta Trop 2012; 124: 185-191. https://doi.org/10.1016/j.actatropica.2012.08.005
  9. Schiesselman JJ. Case-Control studies. Design, Conduct, Analysis. New York, USA. Oxford University Press. 1982, pp. 1-354.
  10. Tammam AE, Haridy MA, Abdellah AH, Ahmed SR, Fayed HM, AL Sammani MA. Seroepidemiology of Toxoplasma gondii infection in women with first trimester spontaneous miscarriage in Qena governorate, Egypt. J Clin Diagn Res 2013; 7: 2870-2873.
  11. Chintapally S, Padmaja, IJ. Seroprevalence of toxoplasmosis in antenatal women with bad obstetric history. Trop Parasitol 2013; 3: 62-66. https://doi.org/10.4103/2229-5070.113915
  12. Senthamarai S, Sivasankari S, Apurba SS, Sandhya BK, Kumudavathi MS, Anitha C, Amshavathani SK. Seroprevalence of toxoplasmosis in pregnant women with bad obstetric history in a tertiary care hospital, Kanchipuram-a pilot study. Disease 2013; 3: 29-32.
  13. Hussein AH, Ali AE, Saleh MH, Nagaty IM, Rezk AY. Seropreva lence of Toxoplasma infection in Qualyobia governorate, Egypt. J Egypt Soc Parasitol 2001; 31: 355-363.
  14. Zemene E, Yewhalaw D, Abera S, Belay T, Samuel A, Zeynudin A. Seroprevalence of Toxoplasma gondii and associated risk factors among pregnant women in Jimma town, south western Ethiopia. BMC Infect Dis 2012; 12: 337. https://doi.org/10.1186/1471-2334-12-337
  15. Spalding SM, Amendoeira MR, Klein CH, Ribeiro LC. Serological screening and toxoplasmosis exposure factors among pregnant women in south of Brazil. Rev Soc Bras Med Trop 2005; 38: 173-177. https://doi.org/10.1590/S0037-86822005000200009
  16. Malarvizhi A, Viswanathan T, Lavanya V, Arul Sheeba Malar S, Moorthy K. Seroprevalence of Toxoplasma gondii in pregnant women. J Public Health Epidemiol 2012; 4: 170-177.
  17. Siddiqui N, Shujatullah F, Khan HM, Rabbani T, Khan PA. Socioeconomic status and prevalence of toxoplasmosis in pregnant women with bad obstetric history. J Immunol Vaccine Technol 2014; 1: 101-103.
  18. Li XL, Wei HX, Zhang H, Peng HJ, Lindsay DS. A meta-analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection. PLoS One 2014; 9: e97775. https://doi.org/10.1371/journal.pone.0097775
  19. Ajayi GO, Omilabu SA. Prenatal diagnosis of cytomegalovirus (CMV), rubella, toxoplasmosis, varicella, parvovirus, herpes simplex and syphilis. The lagos programme experience. Clin Exp Obstet Gynecol 2010; 37: 37-38. https://doi.org/10.1016/j.ogc.2010.01.001
  20. Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, Malm G, Salt A, Freeman K, Petersen E, Gilbert RE, for the European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med 2010; 7: e1000351. https://doi.org/10.1371/journal.pmed.1000351
  21. Liu Q, Wei F, Gao S, Jiang L, Lian, H, Yuan B, Yuan Z, Xia Z, Liu B, Xu X, Zhu XQ. Toxoplasma gondii infection in pregnant women in China. Trans R Soc Trop Med Hyg 2009; 103: 162-166. https://doi.org/10.1016/j.trstmh.2008.07.008
  22. Mohammed TK. Seroprevalence of Toxoplasma gondii among pregnant women in Baghdad city. Iraq Acad Sci J 2011; 24: 21-28.

Cited by

  1. Is Toxoplasma Gondii Infection a Risk Factor for Leukemia? An Evidence-Based Meta-Analysis vol.22, pp.None, 2015, https://doi.org/10.12659/msm.897155
  2. Comparative and analytical study on active toxoplasmosis to assess the IgG avidity in correlation to serological profile in a cohort of Egyptian patients vol.26, pp.5, 2015, https://doi.org/10.1007/s00580-017-2501-8
  3. Seroprevalence of Anti- Toxoplasma gondii Antibodies Among Lebanese Pregnant Women vol.17, pp.12, 2015, https://doi.org/10.1089/vbz.2016.2092
  4. Molecular and serological prevalence of Toxoplasma gondii in pregnant women and sheep in Egypt vol.10, pp.10, 2017, https://doi.org/10.1016/j.apjtm.2017.09.012
  5. Comparison of Placenta PCR and Maternal Serology of Aborted Women for Detection of Toxoplasma gondii in Ardabil, Iran vol.55, pp.6, 2015, https://doi.org/10.3347/kjp.2017.55.6.607
  6. Toxoplasma gondii seroprevalence among pregnant women attending antenatal clinic in Northern Tanzania vol.46, pp.1, 2018, https://doi.org/10.1186/s41182-018-0122-9
  7. BCG scar, socioeconomic and nutritional status: a study of newborns in urban area of Makassar, Indonesia vol.24, pp.6, 2015, https://doi.org/10.1111/tmi.13232
  8. Conhecimento e comportamento preventivo de gestantes sobre Toxoplasmose no município de Imperatriz, Maranhão, Brasil vol.24, pp.10, 2015, https://doi.org/10.1590/1413-812320182410.21702017
  9. Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays vol.33, pp.1, 2019, https://doi.org/10.1128/cmr.00130-18
  10. Toxoplasma gondii seropositivity and the associated risk factors in sheep and pregnant women in El-Minya Governorate, Egypt vol.13, pp.1, 2015, https://doi.org/10.14202/vetworld.2020.54-60
  11. A review on toxoplasmosis in humans and animals from Egypt vol.147, pp.2, 2015, https://doi.org/10.1017/s0031182019001367
  12. The global seroprevalence of anti- Toxoplasma gondii antibodies in women who had spontaneous abortion: A systematic review and meta-analysis vol.14, pp.3, 2015, https://doi.org/10.1371/journal.pntd.0008103
  13. Serological prevalence of toxoplasmosis in pregnant women in Luanda (Angola): Geospatial distribution and its association with socio-demographic and clinical-obstetric determinants vol.15, pp.11, 2015, https://doi.org/10.1371/journal.pone.0241908
  14. Toxoplasmosis in immunocompetent Saudi women: Correlation with vitamin D vol.17, pp.None, 2021, https://doi.org/10.1177/17455065211043844
  15. Distribution of integrons and phylogenetic groups among Escherichia coli causing community-acquired urinary tract infection in Upper Egypt vol.67, pp.6, 2021, https://doi.org/10.1139/cjm-2020-0292
  16. Evaluation of soluble CD279 (sCD279) and CD274 (sCD274) in Iraqi patients with Acute Myeloid Leukemia (AML) with Toxoplasmosis vol.790, pp.1, 2021, https://doi.org/10.1088/1755-1315/790/1/012065